MedPath

RCT on Elderly Patients Undergoing Colorectal Cancer Surgery With Enhanced Geriatric Care

Not Applicable
Completed
Conditions
Colorectal Cancer
Registration Number
NCT02352688
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

This study evaluates the effects of enhanced geriatric input on elderly patients undergoing colorectal cancer surgery. Half of the participants will received additional pre, peri and post-operative care from the geriatric team, while the other half will receive standard surgical care.

Detailed Description

Additional geriatric care involves appropriate assessments and interventions by a multidisciplinary team involving geriatricians, physiotherapist, occupational therapist, surgical team, dietician and social worker. It is divided into three stages of care: 1) preoperative assessment, 2) perioperative care and 3) discharge or rehabilitation. In preoperative assessment, a comprehensive geriatric assessment will be carried out which encompasses patients medical and social backgrounds, cognitive status, nutritional assessment and risk factors identification. Perioperative care includes a joint care by surgical and geriatric teams aiming to prevent and treat any postoperative complications. Discharge and rehabilitation aim to identifies and facilities any potential discharge problem or accelerates patients for rehabilitation to the appropriate locations.

Standard surgical care will be given to patients who are undergoing colorectal cancer surgery but without the additional input mentioned above.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  1. Consecutive colorectal cancer patients (aged 70 and over) undergoing elective colorectal cancer surgery at the Prince of Wales Hospital, Shatin, Hong Kong
  2. American Society of Anaesthesiologists fitness score of I, II or III
Exclusion Criteria
  1. Colorectal cancer patients aged 69 or under undergoing colorectal surgery
  2. Patients undergoing emergency colorectal cancer resection
  3. Patients with benign pathology
  4. Patients with evidence of locally advanced or metastatic spread of their primary disease
  5. Patient who are unable to give informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Length of postoperative hospital stayup to 90 days
Secondary Outcome Measures
NameTimeMethod
30-day morbidity30 day from time of surgery
30-day mortality30 day from time of surgery

Trial Locations

Locations (1)

Prince of Wales Hospital

🇭🇰

Hong Kong, Hong Kong

Prince of Wales Hospital
🇭🇰Hong Kong, Hong Kong

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.